Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
JAMA (2021) Vol. 325, Iss. 7, pp. 669-669
Closed Access | Times Cited: 1688

Showing 1-25 of 1688 citing articles:

Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 5, pp. 409-436
Open Access | Times Cited: 2964
Colorectal cancer statistics, 2023
Rebecca L. Siegel, Nikita Sandeep Wagle, Andrea Cercek, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 233-254
Open Access | Times Cited: 2635
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Zhenling Liu, Huanhuan Chen, Lili Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 517
Clinical management of metastatic colorectal cancer in the era of precision medicine
Fortunato Ciardiello, Davide Ciardiello, Giulia Martini, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 4, pp. 372-401
Open Access | Times Cited: 371
Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
Yi Bao, Jianning Zhai, Huarong Chen, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1497-1509
Open Access | Times Cited: 125
The current understanding on the impact of KRAS on colorectal cancer
Mingjing Meng, Keying Zhong, Ting Jiang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111717-111717
Open Access | Times Cited: 122
Metabolism and Colorectal Cancer
Joseph C. Sedlak, Ömer Yılmaz, Jatin Roper
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 467-492
Open Access | Times Cited: 99
Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome
Jing Sun, Jianhui Zhao, Fangyuan Jiang, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 92
Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
Hannah N. Bell, Amanda K. Huber, Rashi Singhal, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 134-149.e6
Open Access | Times Cited: 87
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
Haili Wu, Jin’e Du, Chenglu Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3544-3544
Open Access | Times Cited: 76
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 74
Acetyltransferase fromAkkermansia muciniphilablunts colorectal tumourigenesis by reprogramming tumour microenvironment
Yi Jiang, Yuejie Xu, Chang Zheng, et al.
Gut (2023) Vol. 72, Iss. 7, pp. 1308-1318
Closed Access | Times Cited: 73
Stage IV Colorectal Cancer Management and Treatment
Oscar Hernandez Dominguez, Sümeyye Yılmaz, Scott R. Steele
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2072-2072
Open Access | Times Cited: 69
Novel strategies to reverse chemoresistance in colorectal cancer
Shu‐Chang Ma, Jiaqi Zhang, Tianhua Yan, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11073-11096
Open Access | Times Cited: 60
Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids
Yunuo Mao, Wei Wang, Jingwei Yang, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 285-304
Open Access | Times Cited: 50
From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 50
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
Esther Strating, Mathijs Verhagen, Emerens Wensink, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Premila D. Leiphrakpam, Chandrakanth Are
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3178-3178
Open Access | Times Cited: 47
Natural Language Processing Applications for Computer-Aided Diagnosis in Oncology
Chengtai Li, Yiming Zhang, Ying Weng, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 286-286
Open Access | Times Cited: 46
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
Wensi Zhao, Jun Lei, Shaobo Ke, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102315-102315
Open Access | Times Cited: 43
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
Cecilia Monge, Changqing Xie, Yuta Myojin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005640-e005640
Open Access | Times Cited: 42
Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics
Alberto Valdeolivas, Bettina Amberg, Nicolas Giroud, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
Patrick W. Underwood, Samantha M. Ruff, Timothy M. Pawlik
Cells (2024) Vol. 13, Iss. 3, pp. 245-245
Open Access | Times Cited: 27
Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges
Soumya Narayana, B.H. Jaswanth Gowda, Umme Hani, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Targeted Therapeutic Strategies for the Treatment of Cancer
Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 461-461
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top